Sygnis AG (LIO1):医療機器:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C7483)
◆英語タイトル:Sygnis AG (LIO1) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7483
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年10月
◆ページ数:46
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥52,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥78,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Sygnis AG (Sygnis), formerly Sygnis Pharma AG is a developer of novel products and tools in the field of molecular biology. The company undertakes development and marketing of new molecular biological technologies for DNA amplification and sequencing. Its offers products such as single cell WGA kits, WGA kits, RCA kit, DNA polymerase, one step RT-PCR kit and one step RT-qPCR kit, single cell reverse transcriptase RNaseH+ and RNaseH- kits, among others. The company’s single cell WGA kit is based on its proprietary primpol technology. Its products are also based on retrotranscriptase technology. Its polymerases provides a wide range of applications for DNA amplification, repair, sequencing, detection and modification of genetic targets of clinical value. The company has operations in Germany and Spain. Sygnis is headquartered in Heidelberg, Germany.

Sygnis AG (LIO1) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Sygnis AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Sygnis AG, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Sygnis AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Sygnis AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Sygnis AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Sygnis AG, Medical Equipment, Deal Details 11
Partnerships 11
VolitionRx Enters Into Licensing Agreement With Innova Biosciences For Biotin Technology 11
ImmunoReagents Enters Into Licensing Agreement With Innova Biosciences For Lightning-Link Technology 12
Sygnis Enters into Agreement with TANON 13
Sygnis Enters into Distribution Agreement with Philekorea Technology, Pharm Tech Korea and Axil Scientific 14
SYGNIS Enters into Distribution Agreement with Lucigen 15
BioCat Enters into Distribution Agreement with Sygnis 16
Mologic Enters into Licensing Agreement with Innova Biosciences 17
Equity Offering 18
Sygnis Raises USD5.2 Million in Private Placement of Shares 18
Sygnis Raises USD6 Million in Private Placement of Shares 19
Sygnis Raises USD5.4 Million in Rights Offering of Shares 21
Acquisition 22
Sygnis Acquires TGR BioSciences for USD12.8 Million 22
Sygnis Acquires Innova Biosciences from Innova Partnerships 23
Sygnis AG – Key Competitors 24
Sygnis AG – Key Employees 25
Sygnis AG – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Financial Announcements 28
Aug 09, 2018: Expedeon reports financial results for the first six months of 2018 and successful execution of name 28
May 11, 2018: Sygnis Reports Strong Financial Results for First Quarter of 2018 30
Apr 25, 2018: SYGNIS announces financial results for fiscal year 2017 32
Nov 08, 2017: SYGNIS reports financial results for the third quarter and first nine months of 2017 34
Aug 03, 2017: SYGNIS reports financial results for the second quarter and first six months of 2017 36
May 11, 2017: SYGNIS reports financial results for first quarter of 2017 38
Corporate Communications 40
Jun 06, 2017: SYGNIS announces Management and Supervisory Board changes 40
Mar 22, 2017: SYGNIS anounces change in guarantee for Spanish government soft loans 41
Mar 01, 2017: SYGNIS announces management changes 42
Product News 43
Dec 06, 2017: SYGNIS Launches TruePrime Apoptotic Cell Free DNA Amplification Kit for the Liquid Biopsy Market 43
Other Significant Developments 44
Mar 15, 2018: SYGNIS announces completion of Sales and Marketing team restructuring to support continued strong revenue growth 44
Mar 07, 2017: SYGNIS launches TrueAdvance amplification service to address quality needs in next-generation sequencing 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Sygnis AG, Medical Equipment, Key Facts, 2017 2
Sygnis AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Sygnis AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Sygnis AG, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Sygnis AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Sygnis AG, Deals By Market, 2012 to YTD 2018 9
Sygnis AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
VolitionRx Enters Into Licensing Agreement With Innova Biosciences For Biotin Technology 11
ImmunoReagents Enters Into Licensing Agreement With Innova Biosciences For Lightning-Link Technology 12
Sygnis Enters into Agreement with TANON 13
Sygnis Enters into Distribution Agreement with Philekorea Technology, Pharm Tech Korea and Axil Scientific 14
SYGNIS Enters into Distribution Agreement with Lucigen 15
BioCat Enters into Distribution Agreement with Sygnis 16
Mologic Enters into Licensing Agreement with Innova Biosciences 17
Sygnis Raises USD5.2 Million in Private Placement of Shares 18
Sygnis Raises USD6 Million in Private Placement of Shares 19
Sygnis Raises USD5.4 Million in Rights Offering of Shares 21
Sygnis Acquires TGR BioSciences for USD12.8 Million 22
Sygnis Acquires Innova Biosciences from Innova Partnerships 23
Sygnis AG, Key Competitors 24
Sygnis AG, Key Employees 25
Sygnis AG, Other Locations 26
Sygnis AG, Subsidiaries 26

List of Figures
Sygnis AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Sygnis AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Sygnis AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Sygnis AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Sygnis AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Sygnis AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Sygnis AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Sygnis AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Sygnis AG (LIO1):医療機器:M&Aディール及び事業提携情報(Sygnis AG (LIO1) - Medical Equipment - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆